The vaccine, based on the beta coronavirus variant, showed 93% efficacy against symptomatic omicron infection for people who had already had Covid, Sanofi said.
A New Covid Vaccine That’s Effective Against Omicron Could Hit The Market This Year
The vaccine, based on the beta coronavirus variant, showed 93% efficacy against symptomatic omicron infection for people who had already had Covid, Sanofi said.